Evommune, Inc.

Evommune is a clinical-stage biotechnology company focused on discovering and developing novel therapies for immune-mediated chronic inflammatory diseases. Its mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation. The company advances a portfolio of differentiated product candidates designed to target key drivers of chronic inflammation, with the goal of addressing serious diseases where existing treatment options remain limited for patients.